Search our research
13866 results
SPCR: Prof G. Lewith: Rosehip for osteoarthritis of hip, hand and knee: A Cochrane review
Osteoarthritis (OA) is a common cause of pain and disability and typically affects the hand, knee and hip joints. Pain relief is the main reason why patients with OA see GPs. However, previous research has shown that current medications such as par...
SPCR: Dr M. Lown: Screeing for Atrial Fibrillation using Economical and Accurate Technology (SAFETY) - a pilot study
This is a case-control study to investigate the accuracy of inexpensive commercial heart-rate/rhythm monitoring devices to detect Atrial Fibrillation (AF) in conjunction with a novel algorithm based on digital entropy.Several relatively low cost prop...
SPCR: Dr M. Santer: Experiences of lower limb cellulitis and cellulitis prevention: a qualitative interview study
Following on from our previous cellulitis research, we are currently conducting a qualitative interview study of Nurses’ EXperiences of preventing lower limb CELlulitis (NEXCEL study).Cellulitis is a painful bacterial infection of the skin and underl...
P Little, NIHR HTA (NHS Bristol CCG lead) - Children's drops for ear pain in acute otitis media: the CEDAR randomised controlled trial
Parents of children suffering with AOM frequently use painkillers (paracetamol and /or ibuprofen) and seek advice from primary care (GPs, Walk in Centres, Out of Hours Centres, and Emergency Departments). AOM is the sixth most common infectious reaso...
Prof P. Little: Screen and TREAtment for Malnutrition (STREAM) Programme
About 10-15% of people over the age of 65 living at home are at risk of malnutrition. In particular poor appetite is an important risk factor for malnutrition and for weight loss, and a risk factor for the development of infections, hospital admissio...
Prof P. Little: Cancer: Life Affirming Survivorship support in Primary care (CLASP)
Roughly 2.5 million people in the UK are cancer ‘survivors’ – meaning people who have finished primary treatment, whether or not they are cured. The number is rising to an estimated 4 million by 2030.Recent national surveys suggest that 47% of surviv...
Prof A. Kendrick: Anti-depressants to prevent relapse in depression (ANTLER)
ANTLER is an individually randomised double blind placebo controlled trial that will recruit patients who have taken antidepressants for at least 9 months but are now well enough to consider stopping the treatment.Eligible participants will be taking...